Metropolitan Life Insurance Company (MetLife)’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,688
Closed -$2.72M 1388
2024
Q1
$2.72M Sell
5,688
-82
-1% -$37.8K 0.12% 153
2023
Q4
$2.7M Sell
5,770
-114
-2% -$53.4K 0.13% 138
2023
Q3
$2.59M Sell
5,884
-337
-5% -$148K 0.13% 134
2023
Q2
$2.84M Sell
6,221
-214
-3% -$97.1K 0.14% 130
2023
Q1
$2.97M Sell
6,435
-1,689
-21% -$784K 0.15% 124
2022
Q4
$4.43M Sell
8,124
-536
-6% -$280K 0.2% 105
2022
Q3
$4.07M Sell
8,660
-143
-2% -$68.1K 0.19% 104
2022
Q2
$4.21M Sell
8,803
-253
-3% -$116K 0.18% 112
2022
Q1
$4.05M Sell
9,056
-8,577
-49% -$3.54M 0.14% 135
2021
Q4
$6.83M Sell
17,633
-700
-4% -$261K 0.09% 172
2021
Q3
$6.6M Sell
18,333
-539
-3% -$195K 0.1% 165
2021
Q2
$6.86M Sell
18,872
-7,848
-29% -$2.83M 0.1% 165
2021
Q1
$8.65M Sell
26,720
-1,527
-5% -$460K 0.13% 137
2020
Q4
$8.61M Sell
28,247
-720
-2% -$220K 0.13% 131
2020
Q3
$9.14M Sell
28,967
-1,181
-4% -$385K 0.15% 113
2020
Q2
$9.27M Sell
30,148
-288
-0.9% -$94.4K 0.16% 108
2020
Q1
$9.21M Sell
30,436
-581
-2% -$202K 0.19% 100
2019
Q4
$10.7M Sell
31,017
-698
-2% -$245K 0.17% 106
2019
Q3
$11.9M Sell
31,715
-1,433
-4% -$507K 0.2% 86
2019
Q2
$10.7M Buy
33,148
+1,354
+4% +$404K 0.18% 95
2019
Q1
$8.57M Sell
31,794
-1,629
-5% -$444K 0.16% 113
2018
Q4
$8.19M Buy
33,423
+109
+0.3% +$30.1K 0.16% 106
2018
Q3
$10.6M Sell
33,314
-801
-2% -$244K 0.18% 96
2018
Q2
$10.5M Buy
34,115
+285
+0.8% +$94.2K 0.17% 104
2018
Q1
$11.8M Buy
33,830
+157
+0.5% +$52.6K 0.17% 89
2017
Q4
$10.3M Sell
33,673
-55,440
-62% -$16.7M 0.14% 104
2017
Q3
$25.6M Sell
89,113
-1,387
-2% -$373K 0.16% 108
2017
Q2
$23.2M Sell
90,500
-1,943
-2% -$486K 0.16% 124
2017
Q1
$22M Sell
92,443
-2,062
-2% -$490K 0.15% 125
2016
Q4
$22M Sell
94,505
-3,751
-4% -$872K 0.16% 124
2016
Q3
$21M Sell
98,256
-2,104
-2% -$456K 0.15% 125
2016
Q2
$22.3M Buy
100,360
+3,440
+4% +$724K 0.17% 114
2016
Q1
$19.2M Sell
96,920
-2,102
-2% -$397K 0.15% 130
2015
Q4
$18.7M Sell
99,022
-5,519
-5% -$1.01M 0.14% 132
2015
Q3
$17.3M Sell
104,541
-5,217
-5% -$874K 0.12% 154
2015
Q2
$17.4M Sell
109,758
-522
-0.5% -$83.6K 0.12% 164
2015
Q1
$17.8M Sell
110,280
-3,365
-3% -$538K 0.13% 158
2014
Q4
$16.8M Sell
113,645
-4,483
-4% -$615K 0.12% 174
2014
Q3
$15.6M Sell
118,128
-5,102
-4% -$644K 0.11% 181
2014
Q2
$14.7M Sell
123,230
-7,760
-6% -$938K 0.1% 202
2014
Q1
$16.2M Sell
130,990
-5,135
-4% -$608K 0.11% 182
2013
Q4
$15.6M Sell
136,125
-9,544
-7% -$1.02M 0.11% 183
2013
Q3
$13.9M Sell
145,669
-3,789
-3% -$350K 0.11% 195
2013
Q2
$12.4M Buy
+149,458
New +$11.6M 0.1% 209

Other funds holding NOC

Metropolitan Life Insurance Company (MetLife)'s NOC Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Northrop Grumman (NOC) in Q2 2024, closing a stake of 5,688 shares — an estimated $2.72M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NOC in Q2 2013 and held it in 44 quarters. The position peaked at $25.6M in Q3 2017. 1,508 funds tracked by Wall St. Rank hold NOC as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Northrop Grumman position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,688 Northrop Grumman shares in Q2 2024, an estimated $2.72M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Northrop Grumman in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Northrop Grumman position peaked at $25.6M in Q3 2017.
  • 1,508 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.